Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Evaluation of the effect of IBsolvMIR® on tissue damage, engraftment and graft-versus host disease

Reference number
Coordinator TIKOMED AB
Funding from Vinnova SEK 500 000
Project duration December 2009 - June 2010
Status Completed

Last updated 25 November 2019

Reference number 2009-03929

Page statistics